Literature DB >> 21277122

The multicenter Italian birth cohort study on incidence and determinants of lower respiratory tract infection hospitalization in infants at 33 weeks GA or more: preliminary results.

Marcello Lanari1, Fulvio Adorni, Michela Silvestri, Alessandra Coscia, Massimo Musicco.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) causes respiratory infections during the first year of life. Very premature infants have more severe diseases and also 'late preterm infants' may be more susceptible to the infection. AIM OF THE STUDY: To evaluate in an Italian cohort the incidence and risk factors of severe hospitalized lower respiratory tract infection (LRTI) induced or not by RSV during the first year of life.
METHODS: A cohort of 33(+0d)-34(+6d) wGA newborns paired with two sex- and age-matched 35(+0d)-37(+6d) wGA and ≥ 38(+0d) wGA newborns were enrolled. Hospitalization for LRTI induced or not by RSV during the first year of life was assessed through phone interview at the end of the RSV season (November-March) and at the completion of the first year of life. The parents were asked to report hospitalization for any reason.
RESULTS: 1064 neonates were enrolled (November 2009-October 2010), 697 had at least one phone follow-up by September 2010. Babies of 33(+0d)-34(+6d) wGA were more frequently conceived through assisted fertilization technologies, born from cesarean delivery had more frequently acute perinatal risk factors and were more frequently twins. After a mean 6 month-follow-up, we registered 29 hospitalizations for LRTI induced or not by RSV. Hospitalizations were slightly and non-significantly more frequent in 33(+0d)-37(+6d) wGA infants. The risk of hospitalization was significantly 60% reduced in breastfed babies and four folds significantly increased during the RSV season.
CONCLUSION: The very preliminary data of this ongoing study suggest that in 'late-preterm' infants some individual/environmental characteristics of the infants play a relevant role in determining the risk of severe RSV infection.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21277122     DOI: 10.1016/j.earlhumdev.2011.01.009

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  8 in total

1.  RSV infection among children born moderately preterm in a community-based cohort.

Authors:  Rolof G P Gijtenbeek; Jorien M Kerstjens; Sijmen A Reijneveld; Eric J Duiverman; Arend F Bos; Elianne J L E Vrijlandt
Journal:  Eur J Pediatr       Date:  2014-09-06       Impact factor: 3.183

Review 2.  Immunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus.

Authors:  Silvia Vandini; Paolo Bottau; Giacomo Faldella; Marcello Lanari
Journal:  Biomed Res Int       Date:  2015-05-06       Impact factor: 3.411

3.  Prenatal tobacco smoke exposure increases hospitalizations for bronchiolitis in infants.

Authors:  Marcello Lanari; Silvia Vandini; Fulvio Adorni; Federica Prinelli; Simona Di Santo; Michela Silvestri; Massimo Musicco
Journal:  Respir Res       Date:  2015-12-22

4.  RSV hospitalisation and healthcare utilisation in moderately prematurely born infants.

Authors:  Deena Shefali-Patel; Mireia Alcazar Paris; Fran Watson; Janet L Peacock; Morag Campbell; Anne Greenough
Journal:  Eur J Pediatr       Date:  2012-07       Impact factor: 3.183

5.  Hospital admission due to respiratory viral infections in moderate preterm, late preterm and term infants during their first year of life.

Authors:  I Olabarrieta; E Gonzalez-Carrasco; C Calvo; F Pozo; I Casas; M L García-García
Journal:  Allergol Immunopathol (Madr)       Date:  2014-11-08       Impact factor: 1.667

6.  Viral lower respiratory tract infections and preterm infants' healthcare utilisation.

Authors:  Simon B Drysdale; Mireia Alcazar-Paris; Theresa Wilson; Melvyn Smith; Mark Zuckerman; Janet L Peacock; Sebastian L Johnston; Anne Greenough
Journal:  Eur J Pediatr       Date:  2014-07-19       Impact factor: 3.183

Review 7.  The use of humanized monoclonal antibodies for the prevention of respiratory syncytial virus infection.

Authors:  Marcello Lanari; Silvia Vandini; Santo Arcuri; Silvia Galletti; Giacomo Faldella
Journal:  Clin Dev Immunol       Date:  2013-06-11

Review 8.  Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease.

Authors:  Josep Figueras-Aloy; Paolo Manzoni; Bosco Paes; Eric A F Simões; Louis Bont; Paul A Checchia; Brigitte Fauroux; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2016-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.